Small RNA has big impact on prostate cancer

microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer, new research concludes. This small RNA fragment hit multiple targets, reducing androgen receptor signaling and reviving the potency of enzalutamide, a treatment for advanced prostate cancer. In addition, miR-124 impeded EZH2 and Src, proteins that contribute to treatment resistance. —> Read More